MDxHealth Amends Biomarker Pact with Veridex

Veridex has received rights to use certain DNA methylation biomarkers for colorectal cancer and prostate cancer screening.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.